These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18582211)

  • 21. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
    Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
    Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the DExH motif of the Japanese encephalitis virus and hepatitis C virus NS3 proteins in the ATPase and RNA helicase activities.
    Utama A; Shimizu H; Hasebe F; Morita K; Igarashi A; Shoji I; Matsuura Y; Hatsu M; Takamizawa K; Hagiwara A; Miyamura T
    Virology; 2000 Aug; 273(2):316-24. PubMed ID: 10915602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity.
    Kim DW; Gwack Y; Han JH; Choe J
    Biochem Biophys Res Commun; 1995 Oct; 215(1):160-6. PubMed ID: 7575585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ELISA for RNA helicase activity: application as an assay of the NS3 helicase of hepatitis C virus.
    Hsu CC; Hwang LH; Huang YW; Chi WK; Chu YD; Chen DS
    Biochem Biophys Res Commun; 1998 Dec; 253(3):594-9. PubMed ID: 9918773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcellular localisation of NS3 in HCV-infected hepatocytes.
    Errington W; Wardell AD; McDonald S; Goldin RD; McGarvey MJ
    J Med Virol; 1999 Dec; 59(4):456-62. PubMed ID: 10534726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
    Nishikawa F; Funaji K; Fukuda K; Nishikawa S
    Oligonucleotides; 2004; 14(2):114-29. PubMed ID: 15294075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
    Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
    Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.
    Chang S; Dolganiuc A; Szabo G
    J Leukoc Biol; 2007 Sep; 82(3):479-87. PubMed ID: 17595379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3.
    Manabe S; Fuke I; Tanishita O; Kaji C; Gomi Y; Yoshida S; Mori C; Takamizawa A; Yosida I; Okayama H
    Virology; 1994 Feb; 198(2):636-44. PubMed ID: 8291245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of the multiple enzymatic activities of the hepatitis C virus NS3 protein.
    Misialek S; Rajagopalan R; Stevens SK; Beigelman L; Seiwert SD; Kossen K
    Anal Biochem; 2009 Nov; 394(1):138-40. PubMed ID: 19591800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
    Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
    Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and biochemical characterization of halisulfate 3 and suvanine as novel inhibitors of hepatitis C virus NS3 helicase from a marine sponge.
    Furuta A; Salam KA; Hermawan I; Akimitsu N; Tanaka J; Tani H; Yamashita A; Moriishi K; Nakakoshi M; Tsubuki M; Peng PW; Suzuki Y; Yamamoto N; Sekiguchi Y; Tsuneda S; Noda N
    Mar Drugs; 2014 Jan; 12(1):462-76. PubMed ID: 24451189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.
    Gal-Tanamy M; Zemel R; Berdichevsky Y; Bachmatov L; Tur-Kaspa R; Benhar I
    J Mol Biol; 2005 Apr; 347(5):991-1003. PubMed ID: 15784258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel high throughput screening assay for HCV NS3 helicase activity.
    Hicham Alaoui-Ismaili M; Gervais C; Brunette S; Gouin G; Hamel M; Rando RF; Bedard J
    Antiviral Res; 2000 Jun; 46(3):181-93. PubMed ID: 10867156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
    Locatelli GA; Gosselin G; Spadari S; Maga G
    J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
    Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ
    J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of enzymatic activity of dengue virus nonstructural protein NS3 nucleoside triphosphatase/helicase by poly(U).
    Junaid M; Angsuthanasombat C; Wikberg JE; Ali N; Katzenmeier G
    Biochemistry (Mosc); 2013 Aug; 78(8):925-32. PubMed ID: 24228882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.